Redefining Cancer Therapeutics with Emerging Drug Strategies and Molecular Insights

This book offers an in-depth exploration of the latest advances in cancer therapeutics, with a strong focus on innovative drug strategies and molecular breakthroughs that are shaping the future of oncology.

This book offers an in-depth exploration of the latest advances in cancer therapeutics, with a strong focus on innovative drug strategies and molecular breakthroughs that are shaping the future of oncology. It explores a broad range of modern treatment approaches, including immunotherapy, targeted therapies, epigenetic modulators, and next-generation drug delivery systems. The chapters explore a wide range of topics including small molecule inhibitors, monoclonal antibodies, nanotechnology-based interventions, and emerging tools like CRISPR and AI-driven drug discovery. A key strength of the book is its integration of scientific innovation with clinical translation and regulatory considerations, offering both depth and practical relevance. By bridging the gap between research and real-world application, this book provides a forward-looking roadmap for the future of cancer care. It is an essential resource for oncologists, biomedical researchers, pharmaceutical professionals, and post-graduate students seeking a clear and up-to-date understanding of current and next-generation cancer treatments.